Courtois, FR
Anthony Courtois, Morlaix FR
Patent application number | Description | Published |
---|---|---|
20130302261 | EXOPOLYSACCHARIDE FOR TREATMENT OR CARE OF SKIN, MUCOUS MEMBRANES, HAIR OR NAILS - A method includes administering a cosmetically or dermopharmaceutically effective quantity of exopolysaccharide of a bacterial strain isolated from | 11-14-2013 |
20150079137 | EXOPOLYSACCHARIDE FOR THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR NAILS - Exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, mucous membranes, hair and/or nails, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, for the aging of skin and in particular for the treatment and/or prevention of wrinkles. | 03-19-2015 |
Anthony Courtois, Saint Renan FR
Patent application number | Description | Published |
---|---|---|
20080292645 | Antibody or Antibody Fragment Coupled with an Immunogenic Agent - An immunogenic conjugate includes a target cell-specific circulating molecule and at least one immunogenic agent, the immunogenic agent being coupled by any appropriate means with the circulating molecule. Also described is a method for preparing the immunogenic conjugate and its use for treating cancers or autoimmune diseases. | 11-27-2008 |
20110245199 | Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration - The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 μg (m) g/ml. | 10-06-2011 |
20140037597 | Sulfated Depolymerized Derivatives of Exopolysaccharides (EPS) From Mesophilic Marine Bacteria, Method For Preparing Same, And Uses Thereof In Tissue Regeneration - The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 μg (m) g/ml. | 02-06-2014 |
Bernard Courtois, Amiens FR
Patent application number | Description | Published |
---|---|---|
20100261894 | METHOD OF ENZYME CLEAVAGE OF POLYSACCHARIDES DERIVED FROM ALGAE - The invention relates to a method for enzyme cleavage of polysaccharides comprising a first sequence [→4)-β-D-GlcpA-(1→4)-α-L-Rhap3 sulphate-(1→] | 10-14-2010 |
Christian Courtois, Tournan En Brie FR
Patent application number | Description | Published |
---|---|---|
20100118913 | METHOD AND APPARATUS FOR RAPID TEMPERATURE MEASUREMENT - A method of using a temperature sensor to determine the temperature of an object is described. The method comprises bringing the temperature sensor into thermal contact with the object to be measured. The temperature sensor is then used to acquire a plurality of temperature readings, the plurality of temperature readings being acquired prior to the temperature sensor reaching thermal equilibrium with the object. At least some of the plurality of temperature readings are then used to determine a pseudo-stable temperature at which the rate of change of temperature readings with time is less than a predetermined rate. The actual temperature of the object may then be predicted from the pseudo-stable temperature. | 05-13-2010 |
David Courtois, Bessancourt FR
Patent application number | Description | Published |
---|---|---|
20110293125 | DEEP-EAR-CANAL HEARING DEVICE - A deep-ear-canal hearing device is worn deep in the ear canal of a user. The hearing device is easy to produce and use, has a small overall size, and can be comfortably worn deep within the auditory canal, in particular in the bony part of the auditory canal as well. The hearing device has a housing, a signal-processing apparatus, and a receiver. The signal-processing apparatus is arranged within the housing. The receiver is merely arranged partly within the housing and another part is arranged outside of the housing. The receiver only being arranged partly within the housing, it is thus not completely surrounded by the housing. Hence, the housing can have a smaller configuration. In the region where the receiver is arranged outside of the housing, the double wall in the form of, the receiver wall and, the housing wall can be dispensed with, which helps in reducing the size. | 12-01-2011 |
Didier Courtois, St-Avertin FR
Patent application number | Description | Published |
---|---|---|
20080200666 | Production Of Glucosamine From Plant Species - The present invention relates to a process for generating glucosamine from plants wherein fresh plant materials, or re-hydrated dried plant materials or plant extracts, are heated at a temperature comprised between 70 and 110° C. for more than 10 hours, characterized in that a glucosamine precursor is added to said plant materials, rehydrated plant materials or plant extracts. | 08-21-2008 |
20080214803 | Production of Glucosamine From Plant Species - The present invention relates to a process for generating glucosamine from plants wherein fresh plant materials, or re-hydrated dried plant materials or plant extracts, are heated at a temperature comprised between 70 and 110° C. for more than hours, characterized in that a fertilizer acting as glucosamine precursor is added during the cultivation of the plants, before the harvest. | 09-04-2008 |
20090060883 | COMPOSITION FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH - The present invention relates to a composition for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders. It also relates to the use of the composition in the manufacture of a nutritional product, a supplement, a treat or a medicament; and a method of promoting bone growth or for the maintenance of bone health, which comprises administering an effective amount of the composition. | 03-05-2009 |
20090304823 | NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH AND METHODS REGARDING SAME - Compositions and methods for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders are presented. The present invention also provides the manufacture of a nutritional product, a supplement or a medicament for promoting bone growth or for the maintenance of bone health and methods regarding same. In an embodiment, the present invention provides a composition comprising an active ingredient having an effective amount of a plant or plant extract containing at least one phytochemical having the ability to induce bone morphogenic protein expression. | 12-10-2009 |
20110028416 | NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH COMPRISING EXTRACTS OF FOR EXAMPLE ROSEMARY OR CARAWAY - Compositions and methods for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders are presented. The present invention also provides the manufacture of a nutritional product, a supplement or a medicament for promoting bone growth or for the maintenance of bone health and methods regarding same. In an embodiment, the present invention provides a composition comprising an active ingredient having an effective amount of a plant or plant extract containing at least one phytochemical having the ability to induce bone morphogenic protein expression. | 02-03-2011 |
20110160136 | POLYPHENOLS FOR THE TREATMENT OF CARTILAGE DISORDERS - Compositions and methods for maintenance of cartilage health or prevention, alleviation and/or treatment of cartilage disorders are presented. The present invention also provides the manufacture of a nutritional product, a supplement or a medicament for promoting cartilage growth or for the maintenance of cartilage health and methods regarding same. In an embodiment, the present invention provides a composition comprising an active ingredient having an effective amount of a plant or plant extract containing at least one phytochemical, in particular polyphenol having the ability to treat or prevent muscular skeletal diseases. | 06-30-2011 |
20120040929 | FOOD COMPOSITION COMPRISING GLUCOSAMINE - The present invention relates to an orally ingestible food or pet food composition or cosmetic composition containing glucosamine generated from plant materials through a drying process for the maintenance of joint health or prevention, alleviation and/or treatment of osteoarthritis, or the improvement of the skin quality and prevention or restoration of age-related alterations of skin. It also relates to the use of the composition in the manufacture of a nutritional product, a supplement, a treat, a medicament or a cosmetic product and methods for the maintenance of bone health, prevention, alleviation and/or treatment of osteoarthritis, improvement of the skin quality and prevention or restoration of age-related alterations of skin which comprises administering an effective amount of the composition. | 02-16-2012 |
20140113014 | CHICORY FOR PREVENTION AND TREATMENT OF NEURODEGENERATION - The invention pertains to a composition comprising chicory, particularly roasted chicory root, for use in the prevention or treatment of a neurodegenerative disorder and/or a loss of cognitive ability. In a further aspect, the invention pertains to a non-therapeutic method for maintaining mental or cognitive capabilities. | 04-24-2014 |
Didier Courtois, Avertin FR
Patent application number | Description | Published |
---|---|---|
20120329756 | FOOD COMPOSITION COMPRISING GLUCOSAMINE - The present invention relates to an orally ingestible food or pet food composition or cosmetic composition containing glucosamine generated from plant materials through a drying process for the maintenance of joint health or prevention, alleviation and/or treatment of osteoarthritis, or the improvement of the skin quality and prevention or restoration of age-related alterations of skin. It also relates to the use of the composition in the manufacture of a nutritional product, a supplement, a treat, a medicament or a cosmetic product and methods for the maintenance of bone health, prevention, alleviation and/or treatment of osteoarthritis, improvement of skin quality and prevention or restoration of age-related alterations of skin which comprises administering an effective amount of the composition. | 12-27-2012 |
Fernand Courtois, Saint-Contest FR
Patent application number | Description | Published |
---|---|---|
20100291891 | IMPROVEMENTS IN OR RELATING TO RADIO RECEIVERS - A radio receiver comprises an input ( | 11-18-2010 |
20110150069 | RF RECEIVER - An RF receiver comprising: an amplifier configured to receive an RF signal over an input bandwidth and to provide an amplified RF signal; an equalizer circuit connected to the amplifier to receive the amplified RF signal and configured to provide an equalized RF signal; a converter module connected to the equalizer circuit and comprising an analog to digital converter configured to convert the equalized RF signal to a digital signal; and a digital signal processing module connected to the receiver module and configured to process the digital signal to provide a plurality of channels at an output of the receiver, wherein the digital signal processing module is further configured to process the digital signal to determine a measure of tilt in the RF signal across the input bandwidth and is connected to the equalizer circuit to provide a control signal for adjusting the measured tilt. | 06-23-2011 |
Genevieve Courtois, Paris FR
Patent application number | Description | Published |
---|---|---|
20150141341 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA - Methods and compositions for the treatment of β-thalassemia are provided. Methods and compositions restore or increase erythrocyte maturation in individuals afflicted with β-TM by preventing proteolysis of GATA-1 protein. Screening methods for identifying agents which bind heat shock protein 70 (HSP-70) and inhibit HSP-70 α-globin binding, but which allow GATA-1 protein-HSP-1 binding in a manner that prevents GATA-1 proteolysis. | 05-21-2015 |
Gilles Courtois, Paris FR
Patent application number | Description | Published |
---|---|---|
20080207517 | SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION - The present invention relates to polypeptides that inhibit the NF-κB signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO. | 08-28-2008 |
20080242601 | Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization - The present invention relates to polypeptides that inhibit the NF-&kgr; B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO. | 10-02-2008 |
20090061480 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 03-05-2009 |
20100144615 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 06-10-2010 |
20110182811 | NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB - The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB. | 07-28-2011 |
Nicolas Courtois, Villeurbanne FR
Patent application number | Description | Published |
---|---|---|
20110254181 | Composite Ceramic Material Comprising Zirconia - The invention relates to a composite ceramic material which comprises: | 10-20-2011 |
20150035210 | Composite Ceramic Material Comprising Zirconia - The invention relates to a composite ceramic material which comprises: | 02-05-2015 |
Patrice Courtois, Sermaise FR
Patent application number | Description | Published |
---|---|---|
20120169095 | FRAME FOR A MOTOR VEHICLE SEAT CUSHION - A cushion structure for a motor vehicle seat including a retractable stop piece capable of preventing an object placed under the cushion from moving towards the front, and means capable of arranging said cushion in a position preventing a passenger from sitting on it. | 07-05-2012 |
Sebastien Courtois, Oyonnax FR
Patent application number | Description | Published |
---|---|---|
20110148103 | DEVICE FOR PROTECTING A FEMALE END OF A THREADED TUBULAR CONNECTION COMPONENT, HAVING AN ANTI-UNSCREWING BRAKE - A device configured to protect a female end of a component of a threaded tubular connection for drilling and working a hydrocarbon well, including an internal threading, annular end, and internal surfaces respectively upstream and downstream of the internal threading and respectively having first and second selected orientations. The device includes a body including an external threading to cooperate with the internal threading and first and second flexible annular type sealing elements respectively upstream and downstream of the external threading to provide first and second seals respectively at the internal and end annular surfaces. The first and second sealing elements have selected third and fourth orientations at least one of which differs by at least 10° from the corresponding second or first orientation before screwing the device onto the female end, and are deformable by axial bending to acquire, by surface contact with the internal annular surface and the annular end surface, an energy at least partially opposing any unintentional unscrewing when the female end is screwed onto the body in a final position. | 06-23-2011 |
Sebastien Courtois, Lavancia-Epercy FR
Patent application number | Description | Published |
---|---|---|
20100089484 | DEVICE FOR PROTECTING A MALE END OF A THREADED TUBULAR CONNECTION COMPONENT, HAVING OPEN AND CLOSED POSITIONS, AND ASSOCIATED METHODS AND MOUNTING MACHINES - A protective device for a male end of a component of a threaded tubular connection for drilling and working hydrocarbon wells is externally provided with at least one threading and includes a free terminal portion. The device includes i) a protector body produced in the form of a first sleeve and arranged to protect at least a portion of the external threading and the free terminal portion, ii) a sealing element for positioning in contact firstly with the component, at least at a portion located downstream of the external threading of the male end, and secondly with the protector body to provide a first seal downstream of the external threading, and iii) a fixing mechanism displacing the sealing element and/or protector body radially towards the component, defining open and closed positions of the device in which the sealing element and/or the protector body are respectively not in contact and in tight contact with the component. Further, the first seal is obtained in the closed position of the device. | 04-15-2010 |
Xavier Courtois, La Chapelle Mouliere FR
Patent application number | Description | Published |
---|---|---|
20090191108 | Zirconium/Praseodymium Oxide NOx Traps and Prufication of Gases Containing Nitrogen Oxides (NOx) Therewith - A method for treating/purification a gas containing nitrogen oxides (NOx) includes conveying same through a NOx trap containing a composition based on a catalyst for oxidizing NOx into NO | 07-30-2009 |
Yves Courtois, Paris FR
Patent application number | Description | Published |
---|---|---|
20130150304 | TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL DEGENERATIVE DISORDER - Treatment of a disease associated with retinal degenerative disorder. The present invention relates to human Transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder. | 06-13-2013 |
Yves Courtois, Boulogne FR
Patent application number | Description | Published |
---|---|---|
20090088721 | Enhanced retinal delivery of a nucleic acid through iontophoresis - The present invention provides a device and a method for the enhanced retinal delivery of nucleic acid therapeutics utilizing iontophoresis to evoke a transient elongation of the Müller Cells of a mammalian eye. The enhanced retinal deposition can be achieved by either a topical application, subconjunctival, or an intravitreal injection of the nucleic acid composition followed by, preceded by, or administered simultaneously with the iontophoretic application. The present invention thus provides a particularly advantageous method for the treatment of ocular diseases comprising the in vivo administration of a nucleic acid capable of alleviating the symptoms of a disease, the delivery of the nucleic acid being enhanced by using iontophoresis. This method can be applied particularly to the diseases of the retina resulting from an alteration of a gene expression and/or the over-expression of particular growth factors. The diseases include, but are not limited to, human ocular retinopathies including, neovascular diseases (Age-Related Macular Edema, Diabetic Retinopathies, Diabetic Macular Edema, etc.) and inherited retinopathies such as retinitis pigmentosa. | 04-02-2009 |